NSU Newsroom

SharkBytes

Horizons

This version of NSU News has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of NSU News, visit news.nova.edu.

This version of SharkBytes has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of SharkBytes, visit sharkbytes.nova.edu.

News Releases Archive

Contact

Division of Public Relations and Marketing Communications
Nova Southeastern University
3301 College Avenue
Fort Lauderdale, Florida 33314-7796

nova.edu/prmc

SharkBytes Archives

Contact

Division of Public Relations and Marketing Communications
Nova Southeastern University
3301 College Avenue
Fort Lauderdale, Florida 33314-7796

communications@nova.edu

NSU Dean of Dental Medicine Joins Vigilant Biosciences, Inc. Board of Directors

Linda Niessen, D.M.D., M.P.H., M.P.P

Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, recently announced the addition of Linda Niessen, D.M.D., M.P.H., M.P.P., dean, NSU’s College of Dental Medicine, to its Board of Directors. The addition of Dr. Niessen brings the number of board members to four.

Niessen has enjoyed a distinguished career within the professional dental community, currently serving as dean and professor at NSU’s College of Dental Medicine. She previously served as a professor at Baylor College of Dentistry, Texas A&M University in Dallas from 1991 to 2013. In addition to her academic career, Niessen has held executive positions at DENTSPLY International, a leading manufacturer and distributor of dental and other consumable medical device products, including most recently as vice president, chief clinical officer and prior as DENTSPLY’s vice president, clinical education.

“We are thrilled to welcome Linda, an esteemed dental professional and educator, to our Board of Directors,” said Matthew Kim, founder, chairman and CEO of Vigilant Biosciences, Inc. “Her background and accomplishments are impressive and will bring enormous value to Vigilant Biosciences. Additionally, Dr. Niessen’s leadership roles and extensive knowledge in this space will be important as we continue to advance our oral cancer risk assessment system towards commercialization.”

Click here to read the press release from Vigilant Biosciences, Inc.